NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Fidelity Securities Fund Acquires 1.8% Stake in Onesource Specialty Pharma

On April 21, Fidelity Securities Fund has made a significant investment in Onesource Specialty Pharma, a contract development and manufacturing organization, by purchasing nearly 1.8 percent of the company's equity stake through open market transactions. This acquisition was made through the Fidelity Blue Chip Growth Fund, which acquired 20.17 lakh shares at a price of Rs 1,530 per share, valued at Rs 308.7 crore.

The acquisition comes as Onesource Specialty Pharma shares experienced a significant recovery, rising seven-tenth of a percent to close at Rs 1,560.7 on the National Stock Exchange. The stock also tested its 200-day EMA intraday, while sustaining above its 20, 50, and 100-day EMAs.

However, other investors in Onesource Specialty Pharma have also been active in the market. Authum Investment & Infrastructure sold 7.77 lakh shares at Rs 1,530.09 per share, valued at Rs 118.9 crore, while Nova Global Opportunities Fund PCC - Touchstone offloaded 10.57 lakh shares at Rs 1,530 per share, amounting to Rs 161.85 crore. As of March 2026, Authum Investment held a 5.16 percent stake in Onesource Specialty.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Key Transactions in Onesource Specialty Pharma

InvestorQuantityPrice per ShareValue
Fidelity Securities Fund20.17 lakhRs 1,530Rs 308.7 crore
Authum Investment & Infrastructure7.77 lakhRs 1,530.09Rs 118.9 crore
Nova Global Opportunities Fund PCC - Touchstone10.57 lakhRs 1,530Rs 161.85 crore

In addition to Onesource Specialty Pharma, shares of Shringar House of Mangalsutra also rallied 1.76 percent to Rs 205.36 on the National Stock Exchange. Thakkar Vardhilal Shivrambhai exited the company by selling its entire stake of 15.55 lakh shares for Rs 31.9 crore at Rs 205.18 per share. However, other investors, including Wiinance Financial Services and Arthkumbh Ventures, were buyers in the company.

Key Transactions in Shringar House of Mangalsutra

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

InvestorQuantityPrice per ShareValue
Thakkar Vardhilal Shivrambhai15.55 lakhRs 205.18Rs 31.9 crore
Wiinance Financial Services7.55 lakhRs 206.31Rs 15.57 crore
Arthkumbh Ventures LLP8 lakhRs 204.13Rs 16.33 crore

Other companies that experienced significant activity in the market include Shyam Telecom and Mayasheel Ventures. Meghna Agarwal acquired 1.09 lakh shares in Shyam Telecom at Rs 12.81 per share, amounting to Rs 14.01 lakh. However, Capacious Wealth Management LLP sold 1.11 lakh shares in Mayasheel Ventures at Rs 56.23 lakh at Rs 50.66 per share.

Investor Takeaway

Investors should be aware of the recent acquisition of Onesource Specialty Pharma by Fidelity Securities Fund.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.